Insider Shareholders with Direct Ownership of Nurix Therapeutics, Inc. (NRIX)
This section provides a comprehensive overview of the insiders with direct ownership of Nurix Therapeutics, Inc. (NRIX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Nurix Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
5,422,549 | 2,000,000 | 3,422,549 $71.4 Million | 3 |
May 06, 2021
Reduced 24.08%
|
|
Column Group L P
> 10% Shareholder |
6,672,548 | 4,000,000 | 1,394,333 $29.1 Million | 2 |
May 05, 2021
Reduced 58.92%
|
|
Hans Van Houte
Chief Financial Officer |
156,639 | 108,306 | 48,333 $1.01 Million | 30 |
Jun 20, 2024
Reduced 29.27%
|
|
Gwenn Hansen
Chief Scientific Officer |
59,488 | 24,483 | 39,601 $826,472 | 51 |
Apr 30, 2024
Reduced 4.82%
|
|
Christine Ring
Chief Legal Officer |
52,676 | 36,886 | 19,838 $414,019 | 56 |
Jun 13, 2024
Reduced 8.59%
|
|
Stefani Wolff
EVP and COO |
4,810 | 1,802 | 6,113 $127,578 | 10 |
May 01, 2023
Reduced 5.3%
|
|
Pierre Beaurang
Chief Business Officer |
64,330 | 60,000 | 4,330 $90,367 | 15 |
Aug 10, 2021
Reduced 30.27%
|